BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6141898)

  • 1. Effect of a new potent H2-receptor antagonist on meal-stimulated gastric acid secretion and serum gastrin concentration in duodenal ulcer patients.
    Brozinsky S; Hogan DL; Isenberg JI; Richardson CT
    Dig Dis Sci; 1984 Feb; 29(2):129-33. PubMed ID: 6141898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiotidine, a new long-acting histamine H2-receptor antagonist: comparison with cimetidine.
    Richardson CT; Feldman M; Brater C; Welborn J
    Gastroenterology; 1981 Feb; 80(2):301-6. PubMed ID: 6108895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cimetidine, a new histamine H2-receptor antagonist, on meal-stimulated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcer.
    Richardson CT; Walsh JH; Hicks MI
    Gastroenterology; 1976 Jul; 71(1):19-23. PubMed ID: 6359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.
    Thomas FJ; Koss MA; Hogan DL; Isenberg JI
    Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mifentidine on peptone meal-stimulated gastric acid secretion and plasma gastrin levels in duodenal ulcer patients.
    Bianchi Porro G; Imbimbo BP; Lazzaroni M
    Agents Actions; 1988 Aug; 25(1-2):22-6. PubMed ID: 3055874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible sustained increase of gastrin and gastric acid secretion in a subgroup of duodenal ulcer patients on long-term treatment with H2 antagonists.
    Kohn A; Annibale B; Prantera C; Giglio L; Suriano G; Delle Fave G
    J Clin Gastroenterol; 1991 Jun; 13(3):284-90. PubMed ID: 1676714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of gastric acid secretion by cimetidine in patients with duodenal ulcer.
    Henn RM; Isenberg JI; Maxwell V; Sturdevant RA
    N Engl J Med; 1975 Aug; 293(8):371-5. PubMed ID: 239346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of H2-receptor antagonists on gastric acid secretion and serum gastrin concentration: a review.
    Richardson CT
    Gastroenterology; 1978 Feb; 74(2 Pt 2):366-70. PubMed ID: 23338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of etintidine in patients with duodenal ulcer.
    Brater DC; Meyers WM; Dandekar KA; Pittman KA; Peterson W
    Eur J Clin Pharmacol; 1982; 23(6):495-500. PubMed ID: 6130952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationship between gastric acidity and gastrin concentration in patients with duodenal or gastric ulcer and in healthy subjects.
    Mahachai V; Walker K; Pinchbeck B; Thomson AB
    Clin Ther; 1985; 7(4):424-41. PubMed ID: 4016826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial gastric, pancreatic, and biliary response to histamine H2-receptor antagonists active duodenal ulcer.
    Longstreth GF; Go VL; Malagelada JR
    Gastroenterology; 1977 Jan; 72(1):9-13. PubMed ID: 11148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of histamine H2-antagonists on serum gastrin levels in gastric lumen-perfused rats].
    Yagita M
    J UOEH; 1988 Jun; 10(2):189-201. PubMed ID: 2900546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric acid secretion is abnormally sensitive to endogenous gastrin released after peptone test meals in duodenal ulcer patients.
    Lam SK; Isenberg JI; Grossman MI; Lane WH; Walsh JH
    J Clin Invest; 1980 Feb; 65(2):555-62. PubMed ID: 7356694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW
    J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 11R, 16, 16-trimethyl prostaglandin E2 on meal-stimulated gastric acid secretion in duodenal ulcer subjects.
    Lenz HJ; Brozinsky S; Koss MA; Hogan DL; Scheinbaum ML; Isenberg JI
    Eur J Clin Pharmacol; 1986; 31(3):281-4. PubMed ID: 3792425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of placebo on meal-stimulated gastric acid secretion and serum gastrin concentration. Studies in healthy volunteers and duodenal ulcer patients.
    Feldman M; Richardson CT
    Dig Dis Sci; 1988 Feb; 33(2):152-6. PubMed ID: 3338362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ranitidine and cimetidine in the inhibition of histamine, sham-feeding, and meal-induced gastric secretion in duodenal ulcer patients.
    Konturek SJ; Obtulowicz W; Kwiecien N; Sito E; Mikos E; Oleksy J
    Gut; 1980 Mar; 21(3):181-6. PubMed ID: 6105116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of an H2-receptor antagonist on food-stimulated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcers. Comparison with an anticholinergic drug.
    Richardson CT; Bailey BA; Walsh JH; Fordtran JS
    J Clin Invest; 1975 Mar; 55(3):536-42. PubMed ID: 234981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of various dose regimens of famotidine on basal nocturnal and meal-stimulated gastric secretion.
    Ryan JR; Chremos AN; Vargas R; Mantell G; Johnson CL; McMahon FG
    Clin Pharmacol Ther; 1987 Aug; 42(2):225-31. PubMed ID: 2886245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of oral nizatidine.
    Vargas R; Ryan J; McMahon FG; Regel G; Offen WW; Matsumoto C
    J Clin Pharmacol; 1988 Jan; 28(1):71-5. PubMed ID: 2895125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.